FDA rejects new use for GSK&s Advair
August 10 2007
GlaxoSmithKline (GSK) said that FDA has rejected the drugmakers supplemental drug application for the 500/50 strength of Advair Diskus (fluticasone ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.